Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1)

Medicine and Dentistry

• Breast Cancer 100%
• Regional Perfusion 50%
• Patient 50%
• Radiation Therapy 25%
• Treatment Duration 25%
• Hormone Therapy 25%
• Tumor Marker 25%
• Breast Cancer Screening 25%
• Bisphosphonate 25%
• Systemic Therapy 25%
• Immunotherapy 25%
• Ovary Function 25%
• Cancer Therapy 25%
• Circulating Tumor Cell 25%
• Mortality 25%
• Auriculotherapy 25%
• Plasma 25%
• Cyclin-Dependent Kinase 25%

Nursing and Health Professions

• Breast Cancer 100%
• Regional Perfusion 50%
• Clinician 25%
• Perioperative 25%
• Quality of Life 25%
• Treatment Duration 25%
• Prevention 25%
• Systemic Therapy 25%
• DNA 25%
• Hormonal Therapy 25%
• Radiotherapy 25%
• Immunotherapy 25%
• Tumor Marker 25%
• Cancer Therapy 25%
• Mortality 25%
• Dose 25%
• Bisphosphonic Acid Derivative 25%